| SKIP000984 | |
| SKIP ID | SKIP000984 |
| Organism(En) | - |
| Organism(Ja) | - |
| Cell Type(En) | - |
| Cell Type(Ja) | - |
| Cell Tissue(En) | fibroblast |
| Cell Tissue(Ja) | 線維芽細胞 |
| Cell Origin | Normal |
| Cell Name 1(En) | BJ1 |
| Cell Name 1(Ja) | BJ1 |
| Cell Name 2(En) | - |
| Cell Name 2(Ja) | - |
| Disease Name 1(Ja) | - |
| ICD Code 1 | - |
| Disease Name 1(En) | - |
| OMIM1 | - |
| Disease Name 2(Ja) | - |
| ICD Code 2 | - |
| Disease Name 2(En) | - |
| OMIM 2 | - |
| Disease Name 3(Ja) | - |
| ICD Code 3 | - |
| Disease Name 3(En) | - |
| OMIM 3 | - |
| Age | - |
| Age Range | 0-9 |
| Sex | Male |
| Race(En) | - |
| Race(Ja) | - |
| Genetic Diagnosis | -- |
| Not Detected | No |
| Description(En) | Normal iPS cell line derived from BJ fibroblast from ATCC |
| Description(Ja) | BJ (ATCC® CRL2522™)由来健常者iPS細胞株 |
| Cell Morphology | human ES-like |
| Grade | Research Grade |
| Vector | Retrovirus |
| Transgene | OCT4, SOX2, KLF4, and MYC |
| Adhesiveness | - |
| Feeder | Yes |
| Feeder Cell | mEFs |
| Medium | DMEM/F12, 20% knockout serum replacement, 1 mM L-glutamine, 0.1 mM non-essential amino acids, beta-ME and 10 ng/ml FGF2 |
| Genome Editing | - |
| CO2 | - |
| Mycoplasma | - |
| Detection of Contaminants Mycoplasma | - |
| Pluripotent Markers | Yes |
| Pluripotent Markers Assay | Immunohistochemistry |
| in vitro Differentiation | - |
| in vitro Differentiation Assay | - |
| in vivo Differentiation | - |
| in vivo Differentiation Assay | - |
| Other 1 Assay | Yes |
| Other 1 Assay Method | Differentiation |
| Other 2 Assay | Yes |
| Other 2 Assay Method | RT-PCR |
| Other 3 Assay | No |
| Other 3 Assay Method | - |
| Karyotype | Yes |
| Karyotype Assay | - |
| Remaining Vector Detection | Yes |
| Remaining Vector Detection Assay | RT-PCR |
| STR | - |
| HLA | - |
| Stem Cell Transcriptome analysis | - |
| Stem Cell Transcriptome analysis Assay | - |
| Author Name(En) | Tony Hunter |
| Author Name(Ja) | Tony Hunter |
| Author Organization(En) | Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States |
| Author Organization(Ja) | Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States |
| Author Contact Email | hunter[at]salk[dot]edu |
| PI Organization(En) | Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States |
| PI Organization(Ja) | Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States |
| PI Name(En) | Tony Hunter |
| PI Name(Ja) | Tony Hunter |
| PI Contact Email | hunter[at]salk[dot]edu |
| Availability | Information Only |
| Provider Organization(En) | Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States |
| Provider Organization(Ja) | Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States |
| Provider Email | hunter[at]salk[dot]edu |
| Provider URL | - |
| Ethical Statement(En) | - |
| Ethical Statement(Ja) | - |
| Terms of Use(En) | - |
| Terms of Use(Ja) | - |
| PubMed ID | 27008180 |
| DOI | 10.7554/eLife.13378 |
| Title | Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. |
| Authors | Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C, Berggren T, Evans RM, Gage FH, Hunter T |
| Journal | Elife |
| Year | 2016 |
| Volume | 5 |
| Issue | - |
| Pages | - |
| URL | http://www.ncbi.nlm.nih.gov/pubmed/27008180 |
| Free input | - |
| Note | - |